Acasă › Cancer pulmonar cu celule non-pătrate › Ohio › Toledo
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Toledo, OH
17 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Toledo (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · La 8 mi distanță
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial
În curs de recrutareFaza 3
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
În curs de recrutareFaza 1
- Site 06, Maumee · La 9 mi distanță
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
În curs de recrutareFaza 3
- Taylor Cancer Research Center, Maumee · La 9 mi distanță
Pan-tumor MRD Study
În curs de recrutareStudiu observațional
- Taylor Cancer Research Center, Maumee · La 9 mi distanță
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
În curs de recrutareFaza 3
- Research Site, Toledo
- Research Site, Maumee · La 9 mi distanță
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Mercy Health - Perrysburg Cancer Center /ID# 270536, Perrysburg · La 8 mi distanță
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
În curs de recrutareStudiu observațional
- Toledo Clinic Cancer Center, Toledo
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- Mercy Health - Saint Anne Hospital, Toledo
- Mercy Health - Perrysburg Hospital, Perrysburg · La 8 mi distanță
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
În curs de recrutareFaza 1/2
- Taylor Cancer Research Center, Maumee · La 9 mi distanță
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Maumee · La 9 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
În curs de recrutareFaza 2/3
- ProMedica Flower Hospital, Sylvania · La 9 mi distanță
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
În curs de recrutareFaza 1/2
- Taylor Cancer Research Center, Maumee · La 9 mi distanță
GEMINI-NSCLC: NSCLC Biomarker Study
În curs de recrutareStudiu observațional
- Taylor Cancer Research Center, Maumee · La 9 mi distanță
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
În curs de recrutareFaza 1/2
- Taylor Cancer Research Center (site 204), Maumee · La 9 mi distanță
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY120 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH56 studii
- Washington, DC55 studii
Alte studii în Toledo
- Cancer ovarian12 studii
- Cancer pulmonar11 studii
- Cancer metastatic10 studii
- Accident vascular cerebral9 studii
- Cancer endometrial8 studii
- Melanom8 studii
- Cancer pancreatic8 studii
- Carcinom cu celule scuamoase de cap și gât8 studii
- Cancer esofagian7 studii
- Cancer de prostată7 studii
- Insuficiență cardiacă7 studii
- Cancer colorectal7 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.